Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders

EQS-News: Vitruvia Medical AG / Key word(s): AGM/EGM Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders 28.07.2023 / 08:17 CET/CEST The issuer is solely responsible for the content of this announcement. Vitruvia Medical AG announces that the Company's shareholders approved all proposals on the agenda of the Annual General Meeting held in Baden (AG) on July 26, 2023. A total of 1,110,582 voting shares, representing 44.2% of the total share capital, were represented at this Annual General Meeting.   Markus A. Bertschin, Chairman of the Board of Directors thanked the shareholders for their trust in our company and welcomed our new Board member Mr. Claus Wiest, Managing Director of our investment LT technologies GmbH & Co. KG.     Vitruvia Medical AG   Board of Directors 28.07.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	Vitruvia Medical AG
	Kesselackerstr. 18
	5611 Anglikon
	Switzerland
Phone:	[phone]
E-mail:	[e-mail]
Internet:	www.vitruvia-med.com
ISIN:	CH0461931419
WKN:	A2PDWF
Listed:	Regulated Unofficial Market in Munich
EQS News ID:	1690515

End of News	EQS News Service

1690515  28.07.2023 CET/CEST